On the public citation graph

The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990–2017*

0 signed · 651 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jamadermatol.2016.5538openalex-snapshot
Global Skin Disease Morbidity and Mortality
inferredcites →https://doi.org/10.1002/0470011815.b2a4a046openalex-snapshot
M edical E xpenditure P anel S urvey ( MEPS )
inferredcites →https://doi.org/10.1016/j.det.2017.02.006openalex-snapshot
An Update on the Pathophysiology of Atopic Dermatitis
inferredcites →https://doi.org/10.1016/j.jaad.2018.05.1241openalex-snapshot
A systematic review and meta-analysis of the prevalence and phenotype of adult-onset atopic dermatitis
inferredcites →https://doi.org/10.1016/j.jaci.2007.08.066openalex-snapshot
The role of atopic sensitization in flexural eczema: Findings from the International Study of Asthma and Allergies in Childhood Phase Two
inferredcites →https://doi.org/10.1016/j.jaci.2009.10.009openalex-snapshot
Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three
inferredcites →https://doi.org/10.1016/j.jaci.2013.08.031openalex-snapshot
Adult eczema prevalence and associations with asthma and other health and demographic factors: A US population–based study
inferredcites →https://doi.org/10.1016/j.jaci.2019.05.040openalex-snapshot
Clinical onset of atopic eczema: Results from 2 nationally representative British birth cohorts followed through midlife
inferredcites →https://doi.org/10.1016/j.jaip.2017.10.024openalex-snapshot
Health Care Resource Utilization and Costs Among Adults with Atopic Dermatitis in the United States: A Claims-Based Analysis
inferredcites →https://doi.org/10.1016/j.jaip.2019.08.030openalex-snapshot
Atopic Eczema in Adulthood and Risk of Depression and Anxiety: A Population-Based Cohort Study
inferredcites →https://doi.org/10.1016/j.jid.2016.07.012openalex-snapshot
The Burden of Atopic Dermatitis: Summary of a Report for the National Eczema Association
inferredcites →https://doi.org/10.1016/j.jid.2018.03.300openalex-snapshot
294 A systematic review and meta-analysis of the prevalence and phenotype of adult-onset atopic dermatitis
inferredcites →https://doi.org/10.1016/j.jid.2018.08.035openalex-snapshot
Are Environmental Factors for Atopic Eczema in ISAAC Phase Three due to Reverse Causation?
inferredcites →https://doi.org/10.1016/j.jpeds.2015.10.077openalex-snapshot
The Financial and Emotional Impact of Atopic Dermatitis on Children and Their Families
inferredcites →https://doi.org/10.1016/j.pedhc.2006.04.009openalex-snapshot
Atopic Dermatitis in Italian Children: Evaluation of Its Economic Impact
inferredcites →https://doi.org/10.1016/s0140-6736(06)68770-9openalex-snapshot
Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data
inferredcites →https://doi.org/10.1016/s0140-6736(18)32203-7openalex-snapshot
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017
inferredcites →https://doi.org/10.1016/s0140-6736(97)07302-9openalex-snapshot
Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC
inferredcites →https://doi.org/10.1111/1346-8138.15048openalex-snapshot
Burden of atopic dermatitis in Asia
inferredcites →https://doi.org/10.1111/all.12270openalex-snapshot
New insights into the epidemiology of childhood atopic dermatitis
inferredcites →https://doi.org/10.1111/all.13320openalex-snapshot
The prevalence of atopic dermatitis beyond childhood: A systematic review and meta‐analysis of longitudinal studies
inferredcites →https://doi.org/10.1111/all.13401openalex-snapshot
Epidemiology of atopic dermatitis in adults: Results from an international survey
inferredcites →https://doi.org/10.1111/all.13946openalex-snapshot
The exposome in atopic dermatitis
inferredcites →https://doi.org/10.1111/bjd.18442openalex-snapshot
The cost of childhood atopic dermatitis in a multi‐ethnic Asian population: a cost‐of‐illness study
inferredcites →https://doi.org/10.1111/bjd.18636openalex-snapshot
Atopic dermatitis: economic burden and strategies for high‐quality care
inferredcites →https://doi.org/10.1111/j.1365-2133.2009.09261.xopenalex-snapshot
How well do questionnaires perform compared with physical examination in detecting flexural eczema? Findings from the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Two
inferredcites →https://doi.org/10.1111/jdv.15581openalex-snapshot
Importance of out‐of‐pocket costs for adult patients with atopic dermatitis in France
inferredcites →https://doi.org/10.1371/journal.pone.0039803openalex-snapshot
Investigating International Time Trends in the Incidence and Prevalence of Atopic Eczema 1990–2010: A Systematic Review of Epidemiological Studies
inferredcites →https://doi.org/10.2340/00015555-3102openalex-snapshot
Out-of-pocket Costs for Individuals with Atopic Eczema: A Cross-sectional Study in Nine European Countries
inferredcites →https://doi.org/10.4135/9781483349985.n242openalex-snapshot
Medical Expenditure Panel Survey (MEPS)
inferredcites →https://doi.org/10.7326/m18-2246openalex-snapshot
Prevalence of Atopic Eczema Among Patients Seen in Primary Care: Data From The Health Improvement Network

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4749008openalex-extracted
The Combined Effects of Short-Term Exposure to Multiple Meteorological Factors on Eczema Onset in Two Cities of China
inferred← citeshttps://doi.org/10.2139/ssrn.4797649openalex-extracted
Unveiling New Protein Biomarkers and Therapeutic Targets for Inflammatory Skin Diseases Through Integrated Analysis of Human Plasma Proteomics and Genomics
inferred← citeshttps://doi.org/10.1001/jamadermatol.2021.2489openalex-snapshot
Patterns of Atopic Eczema Disease Activity From Birth Through Midlife in 2 British Birth Cohorts
inferred← citeshttps://doi.org/10.1001/jamadermatol.2024.4911openalex-snapshot
Salt and Atopic Dermatitis—Reply
inferred← citeshttps://doi.org/10.1001/jamadermatol.2026.0425openalex-snapshot
Atopic Dermatitis and Academic Performance
inferred← citeshttps://doi.org/10.1001/jamadermatol.2026.1959openalex-snapshot
Online vs In-Person Care for Atopic Dermatitis
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2025.44324openalex-snapshot
Incidence and Remission of Atopic Dermatitis in a German Birth Cohort
inferred← citeshttps://doi.org/10.1002/14651858.cd013870.pub2openalex-snapshot
Phototherapy for atopic eczema
inferred← citeshttps://doi.org/10.1002/9781119709268.rook005openalex-snapshot
Epidemiology of Skin Disease
inferred← citeshttps://doi.org/10.1002/9781119709268.rook041openalex-snapshot
Atopic Eczema
inferred← citeshttps://doi.org/10.1002/alr.23090openalex-snapshot
International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
inferred← citeshttps://doi.org/10.1002/bab.70203openalex-snapshot
Network Pharmacology and Molecular Docking to Elucidate the Anti‐Dermatitic Mechanism of Phytocompounds in Thespesia populnea Flowers
inferred← citeshttps://doi.org/10.1002/bcp.70847openalex-snapshot
Safety, pharmacodynamics and pharmacokinetics of a novel JAK1‐selective inhibitor, IN‐115314, in healthy participants: A first‐in‐human study
inferred← citeshttps://doi.org/10.1002/bmc.5542openalex-snapshot
LC–MS/MS determination of HY072808, a novel candidate for treating atopic dermatitis, and its active metabolite: Application to a first‐in‐human pharmacokinetic study
inferred← citeshttps://doi.org/10.1002/cia2.12303openalex-snapshot
Safety and effectiveness of dupilumab in the real‐world treatment of atopic dermatitis in Japan: 1‐year interim analysis from a post‐marketing surveillance
inferred← citeshttps://doi.org/10.1002/clt2.12318openalex-snapshot
The efficacy and safety of oral microecological agents as add‐on therapy for atopic dermatitis: A systematic review and meta‐analysis of randomized clinical trials
inferred← citeshttps://doi.org/10.1002/clt2.12355openalex-snapshot
Dilemmas of nomenclature: Web search analysis reveals European preferences in atopic skin diseases
inferred← citeshttps://doi.org/10.1002/clt2.70061openalex-snapshot
20 years of the socioeconomic impact of atopic dermatitis and alopecia areata from around the globe
inferred← citeshttps://doi.org/10.1002/clt2.70179openalex-snapshot
Skin Tape Stripping: A Non‐Invasive Approach Linking Epidermal Changes and Systemic Inflammation in Atopic Dermatitis
inferred← citeshttps://doi.org/10.1002/cti2.1290openalex-snapshot
Neuritin, unmasked as a checkpoint for the pathogenesis of allergy and autoimmunity
inferred← citeshttps://doi.org/10.1002/hsr2.70676openalex-snapshot
A Prospective Open‐Label Study of Tolerance and Effectiveness of Sequential Dermocosmetic Treatments Combining Poly‐ l ‐Lysine Biovectors With Vitamins A and C
inferred← citeshttps://doi.org/10.1002/hsr2.71726openalex-snapshot
Peripheral Blood Skin‐Homing T Cells Define Immunological Endotypes in Atopic Dermatitis: A Case–Control Study in a Mexican Population
inferred← citeshttps://doi.org/10.1002/iid3.70028openalex-snapshot
Tacrolimus versus hydrocortisone in management of atopic dermatitis in children, a randomized controlled double‐blind study: New insights on TARC, CTACK, TSLP, and E‐selectin
inferred← citeshttps://doi.org/10.1002/iid3.70453openalex-snapshot
Efficacy, Safety and Immunomodulatory Effect of Intramuscular Injections of Autologous Whole Blood Into Acupoints in Patients With Atopic Dermatitis: A Randomized Controlled Trial
inferred← citeshttps://doi.org/10.1002/imt2.90openalex-snapshot
Microbial network signatures of early colonizers in infants with eczema
inferred← citeshttps://doi.org/10.1002/jat.4786openalex-snapshot
Acute and Subacute Oral Exposure to Inorganic Arsenic Significantly Impacted the Pathology of a Mouse Model With Th2‐ and Th17‐, But Not Th1‐Dependent Allergy Development
inferred← citeshttps://doi.org/10.1002/jvc2.290openalex-snapshot
Clinically meaningful change threshold in health‐related quality of life among patients aged 6 months to 5 years with atopic dermatitis and their caregiver(s)/family
inferred← citeshttps://doi.org/10.1002/jvc2.70286openalex-snapshot
REVEAL AD ‐ Prevalence of Moderate and Severe Atopic Dermatitis in Ireland: A Cross‐ Sectional, Real World Study of a Secondary Care Population
inferred← citeshttps://doi.org/10.1002/jvc2.70425openalex-snapshot
A Practical Guide for Incorporating Emollients in the Treatment of Mild‐to‐Moderate Atopic Dermatitis
inferred← citeshttps://doi.org/10.1002/jvc2.84openalex-snapshot
Dermatologists' perspectives on healthcare of patients with atopic dermatitis: A cross‐sectional study in Germany
inferred← citeshttps://doi.org/10.1002/mbo3.70043openalex-snapshot
Microbiota–Host Interactions: Exploring Their Dynamics and Contributions to Human Diseases
inferred← citeshttps://doi.org/10.1002/mco2.70029openalex-snapshot
Atopic dermatitis: pathogenesis and therapeutic intervention
inferred← citeshttps://doi.org/10.1002/mgg3.70022openalex-snapshot
Genomic Correlation, Shared Loci, and Causal Relationship Between Bullous Pemphigoid and Atopic Dermatitis: A Large‐Scale Genome‐Wide Cross‐Trait Analysis
inferred← citeshttps://doi.org/10.1002/psp4.70150openalex-snapshot
A Model‐Based Meta‐Analysis Framework Quantifying Drivers of Placebo Response in Atopic Dermatitis Trials
inferred← citeshttps://doi.org/10.1002/ski2.133openalex-snapshot
Oral Janus Kinase Inhibitors in the Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis
inferred← citeshttps://doi.org/10.1002/ski2.262openalex-snapshot
A Patient-Centred Conceptual Model of Nocturnal Scratch and its Impact in Atopic Dermatitis: A Mixed-Methods Study Supporting the Development of Novel Digital Measurements
inferred← citeshttps://doi.org/10.1002/ski2.373openalex-snapshot
A Non-Inferiority Clinical Trial Comparing Probiotics and Oral Corticosteroids for the Management of Acute Exacerbation of Atopic Dermatitis Patients
inferred← citeshttps://doi.org/10.1002/smll.74586openalex-snapshot
Gold Nanoparticles‐Embedded Mn/Zn‐MOF with Enhanced Antioxidant Activities for Treating Atopic Dermatitis
inferred← citeshttps://doi.org/10.1007/978-3-031-07950-4_6openalex-snapshot
Contact, Irritant, Atopic, and Stasis Dermatitis of the Lower Extremity
inferred← citeshttps://doi.org/10.1007/978-3-031-12499-0_2openalex-snapshot
Epidemiology of Atopic Eczema
inferred← citeshttps://doi.org/10.1007/978-3-031-41542-5_2openalex-snapshot
Update in Pediatric Allergy
inferred← citeshttps://doi.org/10.1007/978-3-031-63211-2_1openalex-snapshot
A Novel Signature for Distinguishing Non-lesional from Lesional Skin of Atopic Dermatitis Based on a Machine Learning Approach
inferred← citeshttps://doi.org/10.1007/978-3-031-66513-4_2openalex-snapshot
Serological Biomarkers
inferred← citeshttps://doi.org/10.1007/978-3-032-03596-7_3openalex-snapshot
Skincare for All Ages: The Science, Advances and Future of Skincare from Infancy to Adulthood
inferred← citeshttps://doi.org/10.1007/978-3-032-06878-1_1openalex-snapshot
Identification of Sex-Specific Gene Signatures for Atopic Dermatitis Using Machine Learning Models
inferred← citeshttps://doi.org/10.1007/s00203-025-04267-6openalex-snapshot
Probiotics and gut microbiota modulation: implications for skin health and disease management
inferred← citeshttps://doi.org/10.1007/s00204-023-03579-0openalex-snapshot
Chronic oral exposure to low-concentration fumonisin B2 significantly exacerbates the inflammatory responses of allergies in mice via inhibition of IL-10 release by regulatory T cells in gut-associated lymphoid tissue
inferred← citeshttps://doi.org/10.1007/s00204-024-03740-3openalex-snapshot
Sub-acute oral exposure to lowest observed adverse effect level of nivalenol exacerbates atopic dermatitis in mice via direct activation of mitogen-activated protein kinase signal in antigen-presenting cells
inferred← citeshttps://doi.org/10.1007/s00403-024-03046-5openalex-snapshot
The burden of skin diseases in China: global burden of Disease Study 2019
inferred← citeshttps://doi.org/10.1007/s00403-024-03195-7openalex-snapshot
Global, regional, and national burdens of atopic dermatitis under 14: a trend analysis and future prediction based on the global burden of disease study 2019
inferred← citeshttps://doi.org/10.1007/s00403-024-03635-4openalex-snapshot
Causal effects of circulating lipids and lipid-lowering drugs on the risk of atopic dermatitis: a mendelian randomization study
inferred← citeshttps://doi.org/10.1007/s00403-025-04057-6openalex-snapshot
Saccharomyces boulardii (CNCM I-745) ameliorates Ovalbumin-induced atopic dermatitis by modulating the NF-κB signaling in skin and colon
inferred← citeshttps://doi.org/10.1007/s00403-025-04499-yopenalex-snapshot
Cognitive disengagement syndrome symptoms in pediatric atopic dermatitis: behavioral and emotional correlates
inferred← citeshttps://doi.org/10.1007/s00403-026-04926-8openalex-snapshot
Gut microbiome‑based interventions for treatment of atopic dermatitis—a mini review
inferred← citeshttps://doi.org/10.1007/s10238-023-01147-5openalex-snapshot
Serum thymic stromal lymphopoietin (TSLP) levels in atopic dermatitis patients: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1007/s10753-025-02391-5openalex-snapshot
Single-Cell Transcriptomic Characterization of DNCB-Induced Mouse Model Reveals Atopic Dermatitis-Associated Skin Lesions in Skin Microenvironment
inferred← citeshttps://doi.org/10.1007/s10787-025-02087-0openalex-snapshot
Efficacy and safety of tapinarof in atopic dermatitis: a frequentist and bayesian meta-analysis of randomized controlled trials
inferred← citeshttps://doi.org/10.1007/s11095-023-03616-8openalex-snapshot
Integrated Exposure–Response of Dupilumab in Children, Adolescents, and Adults With Atopic Dermatitis Using Categorical and Continuous Efficacy Assessments: A Population Analysis
inferred← citeshttps://doi.org/10.1007/s11357-024-01364-0openalex-snapshot
Inflammation and aging-related disease: A transdisciplinary inflammaging framework
inferred← citeshttps://doi.org/10.1007/s11845-026-04620-8openalex-snapshot
Atopic dermatitis management: integrating disease mechanisms with precision medicine and nanotechnology-based targeted therapies
inferred← citeshttps://doi.org/10.1007/s12016-025-09024-7openalex-snapshot
Allergens in Atopic Dermatitis
inferred← citeshttps://doi.org/10.1007/s12016-026-09141-xopenalex-snapshot
Heterogeneity in Atopic Dermatitis: Ethnic, Anatomical Site, and Age-related Variations
inferred← citeshttps://doi.org/10.1007/s12016-026-09150-wopenalex-snapshot
Sexual Dimorphism in Allergic and Mast Cell-Associated Diseases
inferred← citeshttps://doi.org/10.1007/s12033-025-01528-zopenalex-snapshot
Engineered Extracellular Vesicles for Treatment of Inflammatory Diseases
inferred← citeshttps://doi.org/10.1007/s12325-025-03286-5openalex-snapshot
Burden of Atopic Dermatitis in Patients Initiating Systemic Therapies in the United States
inferred← citeshttps://doi.org/10.1007/s13555-022-00816-9openalex-snapshot
Patient Characteristics, Treatment Patterns, Healthcare Resource Utilization, and Costs of Targeted Therapy-Eligible Atopic Dermatitis Patients in Taiwan—A Real-World Study
inferred← citeshttps://doi.org/10.1007/s13555-022-00819-6openalex-snapshot
Burden of Atopic Dermatitis in Adults and Adolescents: a Systematic Literature Review
inferred← citeshttps://doi.org/10.1007/s13555-022-00857-0openalex-snapshot
Humanistic and Economic Burden of Atopic Dermatitis for Adults and Adolescents in the Middle East and Africa Region
inferred← citeshttps://doi.org/10.1007/s13555-022-00886-9openalex-snapshot
Pimecrolimus for the Treatment of Atopic Dermatitis in Infants: An Asian Perspective
inferred← citeshttps://doi.org/10.1007/s13555-023-00890-7openalex-snapshot
Challenges in the Use of the Treat-to-Target Strategy in Atopic Dermatitis in Latin America: A Case Series Review
inferred← citeshttps://doi.org/10.1007/s13555-024-01157-5openalex-snapshot
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2)
inferred← citeshttps://doi.org/10.1007/s13555-024-01199-9openalex-snapshot
Lebrikizumab Improves Quality of Life and Patient-Reported Symptoms of Anxiety and Depression in Patients with Moderate-to-Severe Atopic Dermatitis
inferred← citeshttps://doi.org/10.1007/s13555-024-01226-9openalex-snapshot
Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment
inferred← citeshttps://doi.org/10.1007/s13555-024-01308-8openalex-snapshot
A Narrative Review of the OX40-OX40L Pathway as a Potential Therapeutic Target in Atopic Dermatitis: Focus on Rocatinlimab and Amlitelimab
inferred← citeshttps://doi.org/10.1007/s13555-025-01347-9openalex-snapshot
The APOLO Study: A Cross-Sectional Analysis of Disease Characteristics and Patient Burden in Moderate-to-Severe Atopic Dermatitis in Portugal
inferred← citeshttps://doi.org/10.1007/s13555-025-01475-2openalex-snapshot
Budget Impact Analysis of Lebrikizumab for Treating Severe Atopic Dermatitis
inferred← citeshttps://doi.org/10.1007/s13555-025-01492-1openalex-snapshot
Rocatinlimab: A Novel T-Cell Rebalancing Therapy Targeting the OX40 Receptor in Atopic Dermatitis
inferred← citeshttps://doi.org/10.1007/s13555-026-01679-0openalex-snapshot
Real-World Effectiveness and Safety of Abrocitinib in Patients with Atopic Dermatitis: A 16-Week Single-Center Retrospective Cohort Study Compared with Upadacitinib and Baricitinib
inferred← citeshttps://doi.org/10.1007/s13555-026-01869-wopenalex-snapshot
Real-World Effectiveness and Safety of 12 Months of Tralokinumab in Patients with Atopic Dermatitis
inferred← citeshttps://doi.org/10.1007/s15007-025-6540-1openalex-snapshot
Biologika in der Therapie der atopischen Dermatitis: zugelassene Wirkstoffe und monoklonale Antikörper in fortgeschrittener klinischer Prüfung
inferred← citeshttps://doi.org/10.1007/s40257-024-00853-4openalex-snapshot
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2)
inferred← citeshttps://doi.org/10.1007/s40257-026-01017-2openalex-snapshot
Identifying the Most Relevant Eczema Area and Severity Index Thresholds from the Patient Perspective in Atopic Dermatitis Treatment
inferred← citeshttps://doi.org/10.1007/s40257-026-01030-5openalex-snapshot
Itch Relief and Quality-of-Life Improvement with Abrocitinib and Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE COMPARE and JADE DARE
inferred← citeshttps://doi.org/10.1007/s40259-024-00668-zopenalex-snapshot
Long-Term Efficacy and Safety of Stapokibart in Adults with Moderate-to-Severe Atopic Dermatitis: An Open-Label Extension, Nonrandomized Clinical Trial
inferred← citeshttps://doi.org/10.1007/s40520-026-03435-yopenalex-snapshot
Assessing disability-adjusted life years (DALY) from multiple medication use and multiple illnesses of older adults in rural Thailand
inferred← citeshttps://doi.org/10.1007/s40521-021-00289-9openalex-snapshot
The Role of the Environment and Exposome in Atopic Dermatitis
inferred← citeshttps://doi.org/10.1007/s40521-025-00382-3openalex-snapshot
Setting Patient-Centered Treatment Goals in Atopic Dermatitis: Shared Decision and A Treat-to-target Strategy
inferred← citeshttps://doi.org/10.1007/s40629-025-00340-0openalex-snapshot
Biologics in the treatment of atopic dermatitis: approved active substances and monoclonal antibodies in advanced clinical trials
inferred← citeshttps://doi.org/10.1007/s42650-023-00072-yopenalex-snapshot
Is Economic Growth Good for Population Health? A Critical Review
inferred← citeshttps://doi.org/10.1007/s42995-025-00284-yopenalex-snapshot
A novel anti-OX40 human monoclonal antibody that blocks OX40/OX40L signaling and depletes OX40+ T cells
inferred← citeshttps://doi.org/10.1007/s43450-024-00523-wopenalex-snapshot
Cimifugin Mechanism of Action from Saposhnikovia divaricata in the Treatment of Atopic Dermatitis
inferred← citeshttps://doi.org/10.1007/s44187-025-00792-xopenalex-snapshot
Effect of probiotic supplementation on atopic dermatitis in adults: an umbrella meta-analysis
inferred← citeshttps://doi.org/10.1016/b978-0-443-13947-5.00039-7openalex-snapshot
Role of regulatory T cells in pathogenesis and therapeutics of atopic dermatitis
inferred← citeshttps://doi.org/10.1016/j.actatropica.2026.108021openalex-snapshot
Toxocara seropositivity in patients with atopic dermatitis and chronic urticaria: Evidence from a matched case-control study
inferred← citeshttps://doi.org/10.1016/j.alit.2025.10.005openalex-snapshot
Age-stratified comorbidity transitions and interconnected mapping of nine allergic diseases
inferred← citeshttps://doi.org/10.1016/j.allmed.2025.100052openalex-snapshot
Advances on the role of mycobiome in atopic dermatitis
inferred← citeshttps://doi.org/10.1016/j.anai.2021.03.001openalex-snapshot
Atopic dermatitis and dementia risk
inferred← citeshttps://doi.org/10.1016/j.anai.2023.11.009openalex-snapshot
Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE– and Institute of Medicine–based recommendations
inferred← citeshttps://doi.org/10.1016/j.anai.2024.12.005openalex-snapshot
Worldwide prevalence of atopic dermatitis in children between 2000 and 2021: A systematic analysis
inferred← citeshttps://doi.org/10.1016/j.anai.2025.05.003openalex-snapshot
Current updates in the epidemiology and comorbidities of atopic dermatitis
inferred← citeshttps://doi.org/10.1016/j.apsb.2024.11.023openalex-snapshot
“Relative symmetry with electronegativity of different key-groups” strategy for MRGPRX2 antagonist design and its effect on antigen-induced pulmonary inflammation
inferred← citeshttps://doi.org/10.1016/j.apsb.2026.01.003openalex-snapshot
Advances of microneedle technology for the treatment of autoimmune diseases
inferred← citeshttps://doi.org/10.1016/j.archger.2025.105867openalex-snapshot
Global, regional and national burden of knee osteoarthritis 1990–2021: A systematic analysis of the Global Burden of Disease study 2021
inferred← citeshttps://doi.org/10.1016/j.bbi.2026.106796openalex-snapshot
Reduced dementia risk in middle-aged and older atopic dermatitis patients treated with dupilumab: A target trial emulation
inferred← citeshttps://doi.org/10.1016/j.bbrc.2023.06.072openalex-snapshot
Sodium thiosulfate ameliorates atopic dermatitis via inhibiting the activation of NLRP3 inflammasome
inferred← citeshttps://doi.org/10.1016/j.bbrc.2025.152431openalex-snapshot
Knockdown of S100A9 inhibits pyroptosis and promotes PPAR signaling pathway in atopic dermatitis
inferred← citeshttps://doi.org/10.1016/j.bcp.2022.115177openalex-snapshot
The contribution of mouse models to understanding atopic dermatitis
inferred← citeshttps://doi.org/10.1016/j.bcp.2026.118535openalex-snapshot
Alnustone ameliorates atopic dermatitis by rebalancing TAp63/ΔNp63 to upregulate filaggrin and restore skin barrier function
inferred← citeshttps://doi.org/10.1016/j.biocel.2025.106850openalex-snapshot
Antigen-presenting cells orchestrate mixed inflammatory endotypes in atopic dermatitis
inferred← citeshttps://doi.org/10.1016/j.bioorg.2024.107481openalex-snapshot
Design, synthesis, and biological evaluation of 2-(2-oxoindolin-3-ylidene)hydrazinecarbothioamides as a potential EGR-1 inhibitor for targeted therapy of atopic dermatitis
inferred← citeshttps://doi.org/10.1016/j.biopha.2024.117321openalex-snapshot
Diterpenoid DGT alleviates atopic dermatitis–like responses in vitro and in vivo via targeting IL-4Rα
inferred← citeshttps://doi.org/10.1016/j.biopha.2025.118349openalex-snapshot
Mitochondrial homeostasis: Exploring their impact on skin disease pathogenesis
inferred← citeshttps://doi.org/10.1016/j.bjorl.2026.101789openalex-snapshot
Atopic dermatitis and chronic sinusitis: a two-sample Mendelian randomized study
inferred← citeshttps://doi.org/10.1016/j.carbpol.2024.122966openalex-snapshot
Polysaccharide-based hydrogels for atopic dermatitis management: A review
inferred← citeshttps://doi.org/10.1016/j.carbpol.2025.124143openalex-snapshot
Modulation of the gut-skin axis by polysaccharides: Mechanisms and therapeutic potential in immune-related skin diseases
inferred← citeshttps://doi.org/10.1016/j.cellimm.2024.104815openalex-snapshot
Identification of the major immune differences in severe asthmatic children according to their atopic dermatitis status
inferred← citeshttps://doi.org/10.1016/j.chom.2021.07.007openalex-snapshot
Guardians of the barrier: Microbiota engage AHR in keratinocytes to maintain skin homeostasis
inferred← citeshttps://doi.org/10.1016/j.coi.2025.102581openalex-snapshot
Epigenetics of atopic dermatitis: pathogenesis and therapeutic prospects
inferred← citeshttps://doi.org/10.1016/j.colsurfb.2026.115653openalex-snapshot
Keratinocyte membrane-coated nanoparticle combined with epidermal-targeted microneedle for targeted therapy of atopic dermatitis
inferred← citeshttps://doi.org/10.1016/j.cstres.2025.02.001openalex-snapshot
Increased intracellular stress responses and decreased KLF2 in adult patients with atopic dermatitis
inferred← citeshttps://doi.org/10.1016/j.cytogfr.2024.01.003openalex-snapshot
Exogenous drug-induced mouse models of atopic dermatitis
inferred← citeshttps://doi.org/10.1016/j.det.2024.04.007openalex-snapshot
Patient Burden of Atopic Dermatitis and Opportunities for Real-World Self-Monitoring
inferred← citeshttps://doi.org/10.1016/j.det.2024.05.004openalex-snapshot
Global Burden of Atopic Dermatitis
inferred← citeshttps://doi.org/10.1016/j.envint.2023.108123openalex-snapshot
Prenatal exposure to selenium, mercury, and manganese during pregnancy and allergic diseases in early childhood: The Japan Environment and Children's study
inferred← citeshttps://doi.org/10.1016/j.envpol.2026.128529openalex-snapshot
Early pregnancy exposure to organophosphate esters and risk of infant atopic dermatitis: Sex-Specific association analyses in a community-based birth cohort
inferred← citeshttps://doi.org/10.1016/j.farma.2023.11.002openalex-snapshot
Medidas de resultados comunicados por el paciente para evaluar la dermatitis atópica
inferred← citeshttps://doi.org/10.1016/j.farma.2024.08.004openalex-snapshot
[Translated article] Patient-reported outcome measures for assessing atopic dermatitis in clinical practice
inferred← citeshttps://doi.org/10.1016/j.fct.2025.115571openalex-snapshot
Investigating the role of mosquito repellents in atopic dermatitis
inferred← citeshttps://doi.org/10.1016/j.fitote.2026.107398openalex-snapshot
Investigating the mechanism of action of the herbal pair Schizonepeta tenuifolia Briq. and Saposhnikovia Divaricata and their active components in common allergic skin diseases
inferred← citeshttps://doi.org/10.1016/j.foodres.2025.116824openalex-snapshot
Macrophage and keratinocyte cell assays suggest that the supercritical CO2 extract of black soybean possesses anti-inflammatory and skin barrier-protective effects
inferred← citeshttps://doi.org/10.1016/j.freeradbiomed.2026.04.134openalex-snapshot
Prolactin drives the pathogenic amplification of atopic dermatitis by promoting CCL17 secretion through activation of the PI3K/AKT pathway
inferred← citeshttps://doi.org/10.1016/j.gendis.2026.102168openalex-snapshot
High-salt microenvironment worsens the progression of atopic dermatitis via activating the SGK–1–mTOR pathway in keratinocytes
inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e38381openalex-snapshot
TMT-proteomics reveals the therapeutic effects of Lianling decoction against atopic dermatitis through Staphylococcus aureus infection
inferred← citeshttps://doi.org/10.1016/j.iac.2025.06.008openalex-snapshot
Real-world Experience with New Systemic Agents for Atopic Dermatitis in the Netherlands
inferred← citeshttps://doi.org/10.1016/j.ijwd.2021.10.002openalex-snapshot
Novel systemic treatments in atopic dermatitis: Are there sex differences?
inferred← citeshttps://doi.org/10.1016/j.ijwd.2021.10.003openalex-snapshot
Dermatology on the global stage: The role of dermatologists in international health advocacy and COVID-19 research
inferred← citeshttps://doi.org/10.1016/j.intimp.2023.111029openalex-snapshot
Emerging trends in clinical research on Janus kinase inhibitors for atopic dermatitis treatment
inferred← citeshttps://doi.org/10.1016/j.intimp.2024.113316openalex-snapshot
Dietary glutamine supplementation improves both Th1 and Th17 responses via CARD11-mTORC1 pathway in murine model of atopic dermatitis
inferred← citeshttps://doi.org/10.1016/j.intimp.2025.115212openalex-snapshot
Myricetin alleviates DNCB-induced atopic dermatitis by modulating macrophage M1/M2 polarization
inferred← citeshttps://doi.org/10.1016/j.jaad.2021.09.018openalex-snapshot
Mixed evidence on the relationship between socioeconomic position and atopic dermatitis: A systematic review
inferred← citeshttps://doi.org/10.1016/j.jaad.2023.05.037openalex-snapshot
Ultraviolet B phototherapy does not increase the risk of skin cancer among patients with atopic dermatitis: A population-based retrospective cohort study
inferred← citeshttps://doi.org/10.1016/j.jaad.2024.05.021openalex-snapshot
Impact of dynamic antibiotic exposure on immune-mediated skin diseases in infants and children: A nationwide population-based cohort study
inferred← citeshttps://doi.org/10.1016/j.jaad.2024.05.023openalex-snapshot
Tapinarof cream 1% once daily: Significant efficacy in the treatment of moderate to severe atopic dermatitis in adults and children down to 2 years of age in the pivotal phase 3 ADORING trials
inferred← citeshttps://doi.org/10.1016/j.jaad.2025.06.042openalex-snapshot
Global, regional, and national burdens of atopic dermatitis from 1990 to 2021: A trend analysis from the Global Burden of Disease Study 2021
inferred← citeshttps://doi.org/10.1016/j.jaad.2025.10.022openalex-snapshot
Prevalence of atopic dermatitis in the United States from 2021 to 2024: Data from the National Health Interview Survey
inferred← citeshttps://doi.org/10.1016/j.jaad.2026.02.034openalex-snapshot
The 487-gene expression profile test guides systemic therapy selection to improve outcomes for patients with atopic dermatitis: Results from a prospective trial
inferred← citeshttps://doi.org/10.1016/j.jaad.2026.02.114openalex-snapshot
Guidelines of care for the primary prevention of atopic dermatitis and awareness of comorbid conditions in pediatric atopic dermatitis
inferred← citeshttps://doi.org/10.1016/j.jaad.2026.06.064openalex-snapshot
Real-world outcomes of 24-week abrocitinib tapering in moderate-to-severe atopic dermatitis: Feasibility and regimen comparison
inferred← citeshttps://doi.org/10.1016/j.jaci.2022.10.023openalex-snapshot
Novel insights into atopic dermatitis
inferred← citeshttps://doi.org/10.1016/j.jaci.2023.10.006openalex-snapshot
The mycobiome in atopic diseases: Inducers and triggers
inferred← citeshttps://doi.org/10.1016/j.jaci.2023.10.017openalex-snapshot
Association between skin barrier development and early-onset atopic dermatitis: A longitudinal birth cohort study
inferred← citeshttps://doi.org/10.1016/j.jaci.2025.02.029openalex-snapshot
Endotypes of atopic dermatitis
inferred← citeshttps://doi.org/10.1016/j.jaip.2021.02.027openalex-snapshot
Measuring Atopic Dermatitis Disease Severity: The Potential for Electronic Tools to Benefit Clinical Care
inferred← citeshttps://doi.org/10.1016/j.jaip.2024.01.020openalex-snapshot
Treatable Traits in Asthma: The Importance of Extrapulmonary Traits—GERD, CRSwNP, Atopic Dermatitis, and Depression/Anxiety
inferred← citeshttps://doi.org/10.1016/j.jaip.2025.04.042openalex-snapshot
Deciding Which Patients With Atopic Dermatitis to Prioritize for Biologics and Janus Kinase Inhibitors
inferred← citeshttps://doi.org/10.1016/j.jaip.2025.06.023openalex-snapshot
Atopic Dermatitis With Comorbid Skin Diseases: Recognition and Successful Treatment
inferred← citeshttps://doi.org/10.1016/j.jddst.2026.108726openalex-snapshot
Next-generation therapies for atopic dermatitis: Translational insights from targeted pathways to nanotechnology-based delivery
inferred← citeshttps://doi.org/10.1016/j.jdin.2024.04.011openalex-snapshot
Skin care habits of patients with eczema at Kiambu Level 5 Hospital, Kiambu county, Kenya: A retrospective cross-sectional study
inferred← citeshttps://doi.org/10.1016/j.jdin.2025.09.010openalex-snapshot
Tralokinumab for moderate-to-severe atopic dermatitis: A viable option for dupilumab nonresponders
inferred← citeshttps://doi.org/10.1016/j.jdin.2025.11.011openalex-snapshot
Patient preferences in the benefit–risk assessment of atopic dermatitis treatments in China: A nationwide survey
inferred← citeshttps://doi.org/10.1016/j.jep.2023.116194openalex-snapshot
Therapeutic effects and mechanisms of Ku-Gan formula on atopic dermatitis: A pilot clinical study and modular pharmacology analysis with animal validation
inferred← citeshttps://doi.org/10.1016/j.jep.2023.116923openalex-snapshot
Qingre Qushi formula suppresses atopic dermatitis via a multi-target mechanism
inferred← citeshttps://doi.org/10.1016/j.jep.2023.117288openalex-snapshot
Polygonum perfoliatum L. ethanol extract ameliorates 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin inflammation
inferred← citeshttps://doi.org/10.1016/j.jff.2026.107269openalex-snapshot
Protective effects of cheese consumption on common chronic inflammatory skin diseases: A two-sample bidirectional mendelian randomization study
inferred← citeshttps://doi.org/10.1016/j.jgr.2026.101154openalex-snapshot
A hydrogel loaded with ginsenosides from forest-cultivated ginseng ameliorates atopic dermatitis symptoms by suppressing inflammation via JAK2/STAT3 signaling pathway
inferred← citeshttps://doi.org/10.1016/j.jid.2022.12.024openalex-snapshot
The Proteome of Hand Eczema Assessed by Tape Stripping
inferred← citeshttps://doi.org/10.1016/j.jid.2023.09.285openalex-snapshot
Atopic Dermatitis and Cardiovascular Risk in Pediatric Patients: A Systematic Review and Meta-Analysis
inferred← citeshttps://doi.org/10.1016/j.jid.2023.10.019openalex-snapshot
Genetic and Immunological Pathogenesis of Atopic Dermatitis
inferred← citeshttps://doi.org/10.1016/j.jid.2024.01.011openalex-snapshot
Adding Fuel to the Fire? The Skin Microbiome in Atopic Dermatitis
inferred← citeshttps://doi.org/10.1016/j.jid.2025.01.014openalex-snapshot
The Impact of Stressful Childhood Life Events on Atopic Dermatitis Disease Activity and Severity
inferred← citeshttps://doi.org/10.1016/j.jid.2025.06.1574openalex-snapshot
Biologic Therapies Targeting Type 2 Signaling in Atopic Dermatitis: A Comparative Review of Structural and Thermodynamic Differences in Mechanism of Action
inferred← citeshttps://doi.org/10.1016/j.jid.2025.07.036openalex-snapshot
Implementing Federated Analysis Using DataSHIELD in the DREAM TO TREAT Atopic Dermatitis Registries Collaboration
inferred← citeshttps://doi.org/10.1016/j.jid.2026.02.017openalex-snapshot
Basophil activity in atopic dermatitis: Distinct immunomodulatory roles of dupilumab and abrocitinib
inferred← citeshttps://doi.org/10.1016/j.jid.2026.08.010openalex-snapshot
Disease progression–dependent neurobehavioral phenotypes of agitation, anxiety, and depression in MC903-induced chronic itch
inferred← citeshttps://doi.org/10.1016/j.joim.2024.07.004openalex-snapshot
Acupuncture ameliorates atopic dermatitis by modulating gut barrier function in a gut microbiota-dependent manner in mice
inferred← citeshttps://doi.org/10.1016/j.joim.2025.03.005openalex-snapshot
Prim-O-glucosylcimifugin mitigates atopic dermatitis by inhibiting Th2 differentiation through LCK phosphorylation modulation
inferred← citeshttps://doi.org/10.1016/j.jpet.2025.103582openalex-snapshot
Difamilast topically ameliorates pruritus, dermatitis, and barrier dysfunction in atopic dermatitis model mice by inhibiting phosphodiesterase 4, especially the 4B subtype
inferred← citeshttps://doi.org/10.1016/j.jtcms.2021.10.002openalex-snapshot
Mechanism of improving skin barrier function in a mouse model of atopic dermatitis using Mahuang Lianqiao Chixiaodou decoction and its disassembled formula
inferred← citeshttps://doi.org/10.1016/j.jtcms.2022.09.001openalex-snapshot
Intervention of the Mahuang Lianqiao Chixiaodou decoction on immune imbalance in atopic dermatitis-like model mice
inferred← citeshttps://doi.org/10.1016/j.lungcan.2025.108685openalex-snapshot
Global, regional, and national economic consequences of tracheal, bronchial, and lung cancer
inferred← citeshttps://doi.org/10.1016/j.med.2022.02.001openalex-snapshot
Dermatosis eritematosas: eccemas
inferred← citeshttps://doi.org/10.1016/j.nutres.2025.05.006openalex-snapshot
Cathelicidin expression in the pathogenesis of atopic dermatitis and the therapeutic potential of vitamin D
inferred← citeshttps://doi.org/10.1016/j.pec.2023.107936openalex-snapshot
The characteristics and efficacy of educational nurse-led interventions in the management of children with atopic dermatitis - An integrative review
inferred← citeshttps://doi.org/10.1016/j.pharmr.2026.100121openalex-snapshot
From neuroimmune circuits to targeted therapy of chronic pruritus
inferred← citeshttps://doi.org/10.1016/j.phymed.2025.156524openalex-snapshot
A topical Chinese herbal inhibits pruritus and skin inflammation via neural TRPM8 in atopic dermatitis
inferred← citeshttps://doi.org/10.1016/j.piel.2025.02.005openalex-snapshot
Factores asociados a la respuesta al tratamiento con fototerapia en pacientes con dermatitis atópica
inferred← citeshttps://doi.org/10.1016/j.piel.2025.07.018openalex-snapshot
Dermatitis atópica y trastornos del espectro autista: una mirada a su asociación y mecanismos compartidos
inferred← citeshttps://doi.org/10.1016/j.pop.2025.05.006openalex-snapshot
Atopic and Contact Dermatitis
inferred← citeshttps://doi.org/10.1016/j.reth.2025.01.001openalex-snapshot
Recent progress in the identification and in vitro culture of skin organoids
inferred← citeshttps://doi.org/10.1016/j.rmed.2025.108212openalex-snapshot
From itchy skin to wheezing: Potential biomarkers and targeted drugs for atopic dermatitis and asthma in children
inferred← citeshttps://doi.org/10.1016/j.tips.2026.03.004openalex-snapshot
Topical difamilast for the treatment of mild-to-moderate atopic dermatitis
inferred← citeshttps://doi.org/10.1016/j.vhri.2024.100987openalex-snapshot
Strategic Approaches to Reducing the Burden of Atopic Dermatitis in the Middle East and Africa Region
inferred← citeshttps://doi.org/10.1016/j.vhri.2025.101506openalex-snapshot
Mapping the Children’s Dermatology Life Quality Index Questionnaire to EQ-5D-Y-3L in Pediatric Patients With Atopic Dermatitis
inferred← citeshttps://doi.org/10.1016/j.waojou.2022.100724openalex-snapshot
Epidemiology of adult patients with atopic dermatitis in AWARE 1: A second international survey
inferred← citeshttps://doi.org/10.1016/j.waojou.2022.100731openalex-snapshot
Eczema among adolescents in Kuwait: Prevalence, severity, sleep disturbance, antihistamine use, and risk factors
inferred← citeshttps://doi.org/10.1016/j.waojou.2024.101017openalex-snapshot
Gut microbiota and plasma metabolites in pregnant mothers and infant atopic dermatitis: A multi-omics study
inferred← citeshttps://doi.org/10.1016/j.waojou.2024.101022openalex-snapshot
COVID-19 related epigenetic changes and atopic dermatitis: An exploratory analysis
inferred← citeshttps://doi.org/10.1016/j.waojou.2025.101043openalex-snapshot
Allergen immunotherapy and dupilumab in atopic dermatitis: Clinical efficacy and disparities in immunological indicators
inferred← citeshttps://doi.org/10.1016/j.xjidi.2024.100284openalex-snapshot
Uncommon Variants in FLG2 and NOD2 Are Associated with Atopic Dermatitis in the Ethiopian Population
inferred← citeshttps://doi.org/10.1016/j.ygeno.2024.110870openalex-snapshot
Single-cell analysis of CD4+ tissue residency memory cells (TRMs) in adult atopic dermatitis: A new potential mechanism
showing the first 200 of 620 · page through all 620
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.